Top

Published in:

01-12-2009 | Review Article

Potentially Inappropriate Medication in Elderly Hospitalized Patients

Authors: Dr Andrea Corsonello, Luigi Pranno, Sabrina Garasto, Paolo Fabietti, Silvia Bustacchini, Fabrizia Lattanzio

Published in: Drugs & Aging | Special Issue 1/2009

Abstract

Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid diseases. This issue is of particular concern, especially in elderly hospitalized patients because hospitalization exposes such individuals to an increased risk of adverse drug reactions (ADRs). The avoidance of medications that are considered to be inappropriate is among the interventions for treatment options in elderly patients. A potentially inappropriate medication (PIM) is a drug in which the risk of an adverse event outweighs its clinical benefit, particularly when there is a safer or more effective alternative therapy for the same condition. Explicit criteria have been developed to identify PIMs and among these, Beers’ criteria are the most frequently applied in the literature. However, evidence suggests that such criteria cannot easily be applied to elderly hospitalized people in European countries; approximately 20% of drugs listed in Beers’ criteria are rarely prescribed or are not available in Europe, and Beers’ listed PIMs are not associated with inhospital mortality, length of hospital stay and/or ADRs in Italian studies. On the contrary, ADRs can contribute to accelerated functional decline in elderly hospitalized patients independently of the use of Beers’ listed PIMs. Therefore, we will review the evidence pertaining to the application of Beers’ criteria in elderly hospitalized patients, while focusing on Italian studies that have investigated the role of PIMs as potential predictors of negative hospital outcomes. In addition, we will also review the available evidence regarding new European criteria on identifying PIMs, because clinical application in elderly hospitalized Europeans is still under investigation.

Marsili M, Sorvillo MP. Previsioni della popolazione residente per sesso, età e regione dal 1.1.2001 al 1.1.2051. Rome: Istituto Nazionale di Statistica, 2001

Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008 Feb; 64(2): 183–99PubMedCrossRef

Laroche ML, Charmes JP, Bouthier F, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009 Jan; 85(1): 94–7PubMedCrossRef

Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005 Aug 10; 294(6): 716–24PubMedCrossRef

Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 Dec 30; 351(27): 2870–4PubMedCrossRef

Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995 Oct 9; 155(18): 1949–56PubMedCrossRef

Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997 Aug; 45(8): 945–8PubMed

Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997 Oct 13; 157(18): 2089–96PubMedCrossRef

Schimmel EM. The hazards of hospitalization. 1964. Qual Saf Health Care 2003 Feb; 12(1): 58–63; discussion 4: 63–4PubMedCrossRef

10.

Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995 Jul 5; 274(1): 35–43PubMedCrossRef

11.

Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22(5): 375–92PubMedCrossRef

12.

Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001 Feb; 49(2): 200–9PubMedCrossRef

13.

Gurwitz JH. Suboptimal medication use in the elderly. The tip of the iceberg. JAMA 1994 Jul 27; 272(4): 316–17PubMedCrossRef

14.

Schmader K, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994 Dec; 42(12): 1241–7PubMed

15.

Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151(9): 1825–32PubMedCrossRef

16.

Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997 Jul 28; 157(14): 1531–6PubMedCrossRef

17.

Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24PubMedCrossRef

18.

Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004 Jan; 79(1): 122–39PubMedCrossRef

19.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 Apr 15; 279(15): 1200–5PubMedCrossRef

20.

Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997 Jan 22–29; 277(4): 301–6PubMedCrossRef

21.

Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997 Jan 22–29; 277(4): 307–11PubMedCrossRef

22.

Leone R, Sottosanti L, Luisa Iorio M, et al. Drug-related deaths: an analysis of the Italian spontaneous reporting database. Drug Saf 2008; 31(8): 703–13PubMedCrossRef

23.

Page II RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006 Dec; 4(4): 297–305PubMedCrossRef

24.

Corsonello A, Pedone C, Corica F, et al. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007 Mar; 3(1): 197–203PubMedCrossRef

25.

Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000 Mar; 34(3): 338–46PubMedCrossRef

26.

Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994 Jul 27; 272(4): 292–6PubMedCrossRef

27.

Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997 Mar; 87(3): 404–9PubMedCrossRef

28.

Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 2002 Jan; 50(1): 26–34PubMedCrossRef

29.

Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005 Mar 16; 293(11): 1348–58PubMedCrossRef

30.

Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005 Jul; 61(5–6): 453–9PubMedCrossRef

31.

Rothberg MB, Pekow PS, Liu F, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med 2008 Mar; 3(2): 91–102PubMedCrossRef

32.

Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22(9): 767–77PubMedCrossRef

33.

Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007 Feb; 63(2): 177–86PubMedCrossRef

34.

Schuler J, Duckelmann C, Beindl W, et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 2008; 120(23–24): 733–41PubMedCrossRef

35.

Chrischilles EA, VanGilder R, Wright K, et al. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J Am Geriatr Soc 2009 Jun; 57(6): 1000–6PubMedCrossRef

36.

Corsonello A, Pedone C, Lattanzio F, et al. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009 Jun; 57(6): 1007–14PubMedCrossRef

37.

Tuttolomondo A, Pedone C, Pinto A, et al. Predictors of outcome in acute ischemic cerebrovascular syndromes: The GIFA study. Int J Cardiol 2008 Apr 25; 125(3): 391–6PubMedCrossRef

38.

Volpato S, Maraldi C, Ble A, et al. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study. Stroke 2004 Apr; 35(4): 913–17PubMedCrossRef

39.

Onder G, Pahor M, Gambassi G, et al. Association between ACE inhibitors use and headache caused by nitrates among hypertensive patients: results from the Italian group of pharmacoepidemiology in the elderly (GIFA). Cephalalgia 2003 Nov; 23(9): 901–6PubMedCrossRef

40.

Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50(12): 1962–8PubMedCrossRef

41.

Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000 Dec; 53(12): 1222–9PubMedCrossRef

42.

Zuccala G, Pedone C, Cocchi A, et al. Older age and inhospital development of hypokalemia from loop diuretics: results from a multicenter survey. GIFA Investigators. Multicenter Italian Pharmacoepidemiologic Study Group. J Gerontol A Biol Sci Med Sci 2000 Apr; 55(4): M232–8PubMedCrossRef

43.

Zuccala G, Pedone C, Cocchi A, et al. Use of calcium antagonists and hemoglobin loss in hospitalized elderly patients: a cohort study. Gruppo Italiano di Farmacoepidemiologia nell’Anziano (GIFA) investigators. Clin Pharmacol Ther 2000 Mar; 67(3): 314–22PubMedCrossRef

44.

Corsonello A, Pedone C, Corica F, et al. Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA). Eur J Epidemiol 1999 Nov; 15(10): 893–901PubMedCrossRef

45.

Crucitti A, Cecchi E, Gensini GF, et al. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell’Anziano. Pharmacol Res 2000 Feb; 41(2): 249–53PubMedCrossRef

46.

Carosella L, Pahor M, Pedone C, et al. Pharmacosurveillance in hospitalized patients in Italy. Study design of the ‘Gruppo Italiano di Farmacovigilanza nell’Anziano’ (GIFA). Pharmacol Res 1999 Sep; 40(3): 287–95PubMedCrossRef

47.

Mansur N, Weiss A, Beloosesky Y. Is there an association between inappropriate prescription drug use and adherence in discharged elderly patients? Ann Pharmacother 2009 Feb; 43(2): 177–84PubMed

48.

Onder G, Landi F, Cesari M, et al. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003 Jun; 59(2): 157–62PubMed

49.

Onder G, Gambassi G, Scales CJ, et al. Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002 Aug; 58(5): 371–7PubMedCrossRef

50.

Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002 Feb; 40(2): 166–76PubMedCrossRef

51.

Landi F, Russo A, Liperoti R, et al. Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 2007 Aug; 63(8): 791–9PubMedCrossRef

52.

Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46(2): 72–83PubMed

53.

O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008 Mar; 37(2): 138–41PubMedCrossRef

54.

Gallagher PF, Barry PJ, Ryan C, et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ criteria. Age Ageing 2008 Jan; 37(1): 96–101PubMedCrossRef

55.

Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 2006 Aug 15; 48(4): 854–906PubMedCrossRef

56.

Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007 Apr; 32(2): 113–21PubMedCrossRef

57.

Lechevallier N, Fourrier A, Berr C. Benzodiazepine use in the elderly: the EVA Study. Rev Epidemiol Sante Publique 2003 Jun; 51(3): 317–26PubMed

58.

Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999 Jul; 15(1): 15–28PubMedCrossRef

59.

Prudent M, Drame M, Jolly D, et al. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging 2008; 25(11): 933–46PubMedCrossRef

60.

Corsonello A, Pedone C, Corica F, et al. Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2005 Sep; 60(9): 1147–51PubMedCrossRef

61.

Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165(7): 790–5PubMedCrossRef

62.

Corsonello A, Pedone C, Corica F, et al. Estimating glomerular filtration rate might help to avoid hypoglycemia. J Am Geriatr Soc 2006 Sep; 54(9): 1469–70PubMedCrossRef

63.

Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009 Jan; 85(1): 103–7PubMedCrossRef

64.

Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166(6): 605–9PubMedCrossRef

65.

Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007 Aug; 63(8): 725–31PubMedCrossRef

66.

Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008 Nov; 37(6): 673–9PubMedCrossRef

67.

Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother 2009 Jul; 43(7): 1239–44PubMedCrossRef

68.

Roth MT, Weinberger M, Campbell WH. Measuring the quality of medication use in older adults. J Am Geriatr Soc 2009 Jun; 57(6): 1096–102PubMedCrossRef

Title: Potentially Inappropriate Medication in Elderly Hospitalized Patients
Authors: Dr Andrea Corsonello
Luigi Pranno
Sabrina Garasto
Paolo Fabietti
Silvia Bustacchini
Fabrizia Lattanzio
Publication date: 01-12-2009
Publisher: Springer International Publishing
Published in: Drugs & Aging / Issue Special Issue 1/2009
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI: https://doi.org/10.2165/11534640-000000000-00000

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Potentially Inappropriate Medication in Elderly Hospitalized Patients

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2009

Development of CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) Project

Foreword

Inappropriate Drug Prescriptions among Older Nursing Home Residents

Conclusions

Opioids for the Treatment of Chronic Non-Cancer Pain in Older People

Antidiabetic Oral Treatment in Older People

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page